Prevalence of obesity is increasing worldwide. As a result, we are seeing more people with obesity related medical conditions. In the current COVID pandemic, we also noticed that people with obesity and
There is an increasing prevalence of obesity and type 2 diabetes despite several government led interventions and diets. This clearly shows that knowledge of healthy eating and increasing activity does not help.
There are hundreds and thousands of reasons for weight gain. Each one of us has a different genetic makeup and we all have different life experiences. Please click here to see the
With every new medication released for weight loss, people want that new medication. When Saxenda® was released people were keen to try this new injection and has been popularly called the “skinny
Prevalence of obesity is rapidly increasing even in the not so developed countries. We know that at least 60% of the people in UK and USA or either overweight or obese.So, is
“Losing weight is a constant battle”. This is what most of my patients say. Despite all the diets, medications and strictly following the advice by experts, weight loss is elusive. People do
Both contain semaglutide, which is a GLP-1 analogue and are produced by Novo Nordisk pharmaceutical company based in Denmark. Ozempic® and Wegovy® are delivered as weekly injections. GLP or Glucagon Like peptide
Sarcopenia and obesity are two conditions associated with body composition, that are prevalent in our population. Let’s take a closer look at what each of these terms means, what they constitute together
Orthorexia Nervosa – how different is it from healthy eating? We have been observing more and more focus on health and healthy eating over recent years. Many ‘health-promoting’ diets have been increasing
People with obesity struggle to lose weight, more so if they have associated medical or psychiatric/psychological problems. Here we discuss a common medical condition, which is Irritable Bowel Syndrome(IBS) and a very
All consultations and prescriptions are carried out by GMC registered medical practitioners.
All dispensing and shipping of medicines are completed by a UK licensed, GPhC registered Pharmacy no: 9011284.
CloudRx is our partner pharmacy and prescribing service.
*Disclaimer: Results may vary from person to person depending on individual engagement and commitment to the programme.
The content of this website is provided for general informational purposes only and is not intended as, nor should it be considered a substitute for, professional medical advice. Do not use the information on this website for diagnosing or treating any medical or health related condition. If you have or suspect you have a medical problem, promptly contact your healthcare provider.
© 2023 The London Obesity Clinic